BiotechTube

2-weeks placebo then gabapentin + 1-week placebo then gabapentin

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
22
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Neuralgia

Conditions

Neuralgia, Neuralgia, Postherpetic

Trial Timeline

Jul 1, 2004 → Jun 1, 2006

NCT ID
NCT00674687

About 2-weeks placebo then gabapentin + 1-week placebo then gabapentin

2-weeks placebo then gabapentin + 1-week placebo then gabapentin is a pre-clinical stage product being developed by Pfizer for Neuralgia. The current trial status is completed. This product is registered under clinical trial identifier NCT00674687. Target conditions include Neuralgia, Neuralgia, Postherpetic.

Hype Score Breakdown

Clinical
5
Activity
2
Company
9
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT00674687Pre-clinicalCompleted

Competing Products

20 competing products in Neuralgia

See all competitors
ProductCompanyStageHype Score
Placebo + DS-5565Daiichi SankyoPre-clinical
23
QUTENZAAstellas PharmaApproved
85
ASP8477 + PlaceboAstellas PharmaPhase 2
52
E2007 (perampanel) + PlaceboEisaiPhase 2
52
E2007EisaiPhase 2/3
65
KHK6188 + PlaceboKyowa KirinPhase 2
52
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
GalcanezumabEli LillyApproved
85
Placebo + Pregabalin SR tablet 165mg/day + Pregabalin SR tablet 330mg/day + Pregabalin SR tablet 660mg/dayJiangsu Hengrui MedicinePhase 3
77
ABT-894 + ABT-894 + ABT-894 + placebo + DuloxetineAbbViePhase 2
52
MK-8291 + PlaceboMerckPhase 1
33
Etoricoxib + PlaceboMerckApproved
85
Cetuximab + PlaceboMerckPhase 2
52
ADL5747 + Placebo + PregabalinMerckPhase 2
52
MK0759MerckPhase 2
52
MK0686MerckPhase 2
52
Comparator: pregabalin + Comparator: Placebo (unspecified)MerckPhase 1
33
EMA401 + PlaceboNovartisPhase 2
52
pregabalinPfizerApproved
84
Lyrica (pregabalin) + PlaceboPfizerApproved
84

Other Products from Pfizer

MeropenemApproved
84
celecoxibApproved
84
13vPnCApproved
84
EtanerceptApproved
84
AtorvastatinApproved
84